Evidence map›Paper›PMID 38911627›Full record

ArticleAnnals of surgery open : perspectives of surgical history, education, and clinical approaches2024

A Path to High-Value Gastric Cancer Surgery Care Delivery.

Swee H Teh, Sharon Shiraga, Aaron M Kellem, Robert A Li, David M Le, Said P Arsalane, Fawzi S Khayat, Yan Li, I-Yeh Gong, Jessica M Lee

Abstract read
In one paragraph

Article in Annals of surgery open : perspectives of surgical history, education, and clinical approaches, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Swee H TehFrom the The Permanente Medical Group, Gastric Cancer Surgery, Northern California, CA.
Sharon ShiragaFrom the The Permanente Medical Group, Gastric Cancer Surgery, Northern California, CA.
Aaron M KellemThe Permanente Consulting and Information Technology Group, Northern California, CA.
Robert A LiFrom the The Permanente Medical Group, Gastric Cancer Surgery, Northern California, CA.
David M LeFrom the The Permanente Medical Group, Gastric Cancer Surgery, Northern California, CA.
Said P ArsalaneFrom the The Permanente Medical Group, Gastric Cancer Surgery, Northern California, CA.
Fawzi S KhayatFrom the The Permanente Medical Group, Gastric Cancer Surgery, Northern California, CA.
Yan LiThe Permanente Medical Group, Gastrointestinal Oncology, Northern California, CA.
I-Yeh GongThe Permanente Medical Group, Gastrointestinal Oncology, Northern California, CA.
Jessica M LeeFrom the The Permanente Medical Group, Gastric Cancer Surgery, Northern California, CA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Objective: To evaluate the feasibility, safety, and effectiveness of a comprehensive regional program, including the Minimally Invasive Recovery and Empowerment Care (MIREC) pathway, that can significantly reduce hospital stays after laparoscopic gastrectomy without increasing adverse events. Background: Cost-effectiveness and improving patient outcomes are crucial in providing quality gastric cancer care worldwide. Methods: To compare the outcomes of gastric cancer surgery using 2 different models of care within an integrated healthcare system from February 2012 to March 2023. The primary endpoint was the length of hospital stay. The secondary endpoints were the need for intensive care unit care, emergency room (ER) visits, readmission, reoperation, and death within 30 days after surgery. Results: There were 553 patients, 167 in the pre-(February 2012-April 2016) and 386 in the post-MIREC period (May 2016-March 2023). Perioperative chemotherapy utilization increased from 31.7% to 76.4% ( Conclusion: This comprehensive regional program, which encompasses regionalization care, laparoscopic approach, modern oncologic care, surgical subspecialization, and the MIREC pathway, can potentially improve gastric cancer surgery outcomes. These benefits include reduced hospital stays and lower complication rates. As such, this program can revolutionize how gastric cancer surgery is delivered, leading to a higher quality of care and increased value to patients.

Indexed as

adjuvant therapygastric cancerlaparoscopic gastrectomylength of staypostoperative recoveryreturn to caresurgery

Identifiers

PMID38911627
PMCPMC11192013

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.